Author Archives: Natalie Themm
AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway” for CNM-Au8 based on neurofilament light (NfL) biomarker data
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society’s 2026 Annual Meeting
VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of clinical research demonstrating the long-term benefit on complications associated with achondroplasia
Two ARUP Medical Directors Receive Career Achievement Awards
Two ARUP Medical Directors Receive Career Achievement Awards
Canary Speech Introduces Free Voice-Based Check-In for Consumers to Help Identify Early Signs of Mental Health Decline
As gaps in early detection persist, a 45-second voice analysis offers a new way to identify signals of stress, anxiety, and depression during Mental Health Awareness Month
What to Know About the Reauthorized SBIR/STTR Grant Programs
What to Know About the Reauthorized SBIR/STTR Grant Programs
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity
Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
Freyya Wins San Antonio TechFuel 2026 Competition
Freyya Wins San Antonio TechFuel 2026 Competition
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting
PhotoPharmics Phase 2 Parkinson’s Disease
PhotoPharmics will be attending the American Academy of Neurology Annual Meeting (AAN) in Chicago, April 18-22.
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
Freyya Selected as Finalist for Tech Fuel 2026
Freyya Selected as Finalist for Tech Fuel 2026
